Antimicrobial Potential of Curcumin: Therapeutic Potential and Challenges to Clinical Applications
Overview
Authors
Affiliations
Curcumin is a bioactive compound that is extracted from and that is known for its antimicrobial properties. Curcuminoids are the main constituents of curcumin that exhibit antioxidant properties. It has a broad spectrum of antibacterial actions against a wide range of bacteria, even those resistant to antibiotics. Curcumin has been shown to be effective against the microorganisms that are responsible for surgical infections and implant-related bone infections, primarily and . The efficacy of curcumin against and , alone or in combination with other classic antibiotics, is one of its most promising antibacterial effects. Curcumin is known to have antifungal action against numerous fungi that are responsible for a variety of infections, including dermatophytosis. Candidemia and candidiasis caused by species have also been reported to be treated using curcumin. Life-threatening diseases and infections caused by viruses can be counteracted by curcumin, recognizing its antiviral potential. In combination therapy with other phytochemicals, curcumin shows synergistic effects, and this approach appears to be suitable for the eradication of antibiotic-resistant microbes and promising for achieving co-loaded antimicrobial pro-regenerative coatings for orthopedic implant biomaterials. Poor water solubility, low bioavailability, and rapid degradation are the main disadvantages of curcumin. The use of nanotechnologies for the delivery of curcumin could increase the prospects for its clinical application, mainly in orthopedics and other surgical scenarios. Curcumin-loaded nanoparticles revealed antimicrobial properties against in periprosthetic joint infections.
Fmoc-FF Nanogel-Mediated Delivery of Doxorubicin and Curcumin in Thyroid Cancer Cells.
Gallo E, Smaldone G, Cimmino L, Braile M, Orlandella F, Luciano N Pharmaceutics. 2025; 17(2).
PMID: 40006633 PMC: 11858838. DOI: 10.3390/pharmaceutics17020263.
Kawee-Ai A Gels. 2025; 11(2).
PMID: 39996668 PMC: 11855317. DOI: 10.3390/gels11020125.
Cardoso-Daodu I, Ilomuanya M Adv Pharmacol Pharm Sci. 2025; 2025:6828052.
PMID: 39949863 PMC: 11824790. DOI: 10.1155/adpp/6828052.
Ferreira S, Grenho L, Fernandes M, Costa Lima S Pharmaceutics. 2025; 17(1).
PMID: 39861755 PMC: 11768553. DOI: 10.3390/pharmaceutics17010108.
Hassanen E, Hassan N, Mehanna S, Hussien A, Ibrahim M, Mohammed F Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 39836252 DOI: 10.1007/s00210-025-03799-4.